Skip to Content

Study of Subcutaneaous Testosterone in Adjuvant Treatment of Postmenopausal Women

Randomized Double-Blind Placebo-Controlled Study of Subcutaneaous Testosterone in Adjuvant treatment of Postmenopausal Women with Aromatase Inhibitor Induces Arthralgias.

Objective

Many women experience muscle pain when taking some hormonal medications for breast cancer treatment. This study is looking at whether or not testosterone can reduce or stop the pain. Women will be slpit into two groups. One group will get testosterone and the other group will get placebo.

IRB Protocol Number
A221102
Principal Investigator(s)
Charles Catcher, MD
Sponsor(s)
National Cancer Institute
Contact
Margaret White, RN OCN, CC at 603-232-8908
How to Participate

Inclustion Criteria:

  • Patients must be receiving Arimidex or Femara hormone therapy for at least 21 days before enrollment;
  • Must have moderate to servere pain in hands, wrists, knees or hips that started after staring the hormone treatment;
  • Treatment commitment is 6 months.

 

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000